-
Bra cup size at age 20 predicts risk of diabetes mellitus in later life.
-
Does erythropoietin worsen cancer death rates? Most hypothyroid patients can be replaced with levothyroxine alone without additional T3. Does aggressive control in type 2 diabetes save lives?
-
Erectile dysfunction (ED) most commonly reflects endothelial dysfunction of the corpora cavernosa. Because the risk factors for ED have been determined to be the same as those for cardiovascular disease (CVD), the concept that ED might actually be a predictor for CVD has garnered some support.
-
Foot reflexology was more effective than non-specific foot massage in reducing daytime urinary frequency.
-
Patients that present with elevated blood pressure (BP) to the emergency department (ED) frequently have elevated BP measurements at home, independent of pain and anxiety. Clinicians must provide close follow up for these patients.
-
The greatest challenge for any potentially mortal disorder is to prove that therapeutic interventions reduce not only disease-specific mortality, but also all-cause mortality.
-
This single center prospective observational study finds that the utility of a routine daily chest x-ray (CXR) for an ICU patient is quite limited. A change in practice to ordering CXR only when clinically indicated did not adversely impact patient outcome but reduced CXR volume and overall costs.
-
Neither training in working techniques nor use of lifting equipment appears to prevent back pain or back-related disability.
-
Lower serum testosterone in men aged 60 and over was associated with increased fracture risk (especially hip and nonvertebral), even after adjusting for other major risk factors for fracture.
-
Wyeth Pharmaceuticals has received approval to market desvenlafaxine for the treatment of depression. The drug is the major active metabolite of venlafaxine (Effexor ). Wyeth has formulated the drug in a once-daily extended-release tablet. It will be marketed under the trade name Pristiq.